Alfonso Dueñas Gonzalez, Medical Oncologist and Senior Researcher at the National Cancer Institute of Mexico, shared a post on X:
“13 Corrected Articles So Far
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).
Saldanha EF, Cordeiro de Lima VC, Fares A, Corassa M, Gil-Santana L, Arrieta O, Soler J, Chamorro DF, Rodrigues J, Carioca Freitas H, Rojas L, Zuluaga J, Cardona AF.
Oncologist. 2025 Feb 6;30(2):oyae347. doi: 10.1093/oncolo/oyae347.
Correction to: Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP)”
Other articles featuring Alfonso Dueñas Gonzalez on OncoDaily.